Advertisement
Codiak BioSciences Inc. (CDAK)
NASDAQ: CDAK
· Real-Time Price · USD
0.06
0.00 (5.26%)
At close: Apr 04, 2023, 8:00 PM
5.26% (1D)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | 33.57M |
| Net Income (ttm) | -29.23M |
| EPS (ttm) | -0.46 |
| PE Ratio (ttm) | -0.12391304347826088 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 12,929,980 |
| Avg. Volume (20D) | 1,599,191 |
| Open | 0.11 |
| Previous Close | 0.06 |
| Day's Range | 0.05 - 0.11 |
| 52-Week Range | 0.02 - 4.25 |
| Beta | 3.93 |
About CDAK
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide target...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 14, 2020
Employees 102
Stock Exchange NASDAQ
Ticker Symbol CDAK
Website https://www.codiakbio.com